Recent cases show labs should be wary of issues such as improper relationships, medical necessity, kickbacks, and potential telehealth fraud.
Seth B. Orkand
Posts by the Author
The end of the COVID-19 public health emergency on May 11 also brings certain flexibilities for labs and other providers to an end.
As we move further into 2023, COVID-19, add-on, and genetic tests will likely remain targets for federal regulators.